Monday, October 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 14, 2026

BNP highlights bullish takeaways on agentic AI, growth in meetings with Salesforce, Workday, Snowflake

View original at seekingalpha.com
BNP highlights bullish takeaways on agentic AI, growth in meetings with Salesforce, Workday, Snowflake [Humans are using laptops and computers to interact with AI, helping them create, code, train AI, or analyze big data with fast, cutting-edge technology.] BNP Paribas highlighted key takeaways, including agentic AI, g…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Companies are coming back to Salesforce after testing solutions from AI startups like Sierra AI and Decagon AI, and after trying DIY AI

    60% confidence
  • Flex Credit revenues expected to start ramping in fiscal year 2027 for new agentic offerings on outcome-based pricing

    60% confidence
  • LLM costs will weigh on gross margins, but Salesforce can secure volume discounts and expects costs per token to come down over time

    60% confidence
  • Salesforce is well-positioned to win in the new agentic layer due to customer data context, existing systems of work, Atlas Reasoning Engine for workflow orchestration, and engagement layer through Slack

    60% confidence
  • Data Cloud offering expected to ramp up in second half, charged on consumption basis based on amount of data

    60% confidence
  • LLM costs will weigh on gross margins, but Salesforce can secure volume discounts and expects costs per token to decline over time

    60% confidence
  • Marketing business will stabilize with new product functionality ramping, but Commerce taking longer to improve due to competitive pressures and R&D resource allocation to AI

    60% confidence
  • Customers are finding value in using Snowflake's own coding tool for data operations because it is better at identifying patterns and context within Snowflake data while benefiting from Snowflake security and governance controls

    60% confidence
  • Snowflake is committed to maintaining product gross margins at 75% this year despite AI product gross margin headwinds

    60% confidence
  • Revenue growth acceleration expected in H2, potentially as early as Q3

    60% confidence
  • Company has not seen any mass piping of data out of Salesforce

    60% confidence
  • Margin targets may be lowered as company focuses on accelerating top-line growth and ensuring product portfolio relevance in agentic AI world

    60% confidence
  • Some customers already replacing third-party point solution functionality by running workflows directly in Snowflake

    60% confidence
  • AI native revenues are likely less than 2% of total revenues but may have already helped drive the Q4 beat

    60% confidence
  • Salesforce is doing all of the right things, but the share price will not likely react until Salesforce can 1) demonstrate stability in its core business and 2) demonstrate continued success and adoption of Agentforce along with Data Cloud

    60% confidence
  • Data Cloud offering expected to ramp in second half, charged on consumption basis based on data amount

    60% confidence
  • Salesforce has not seen any mass piping of data out of Salesforce to date

    60% confidence
  • Workday is returning to organic product focus with goal of delivering revenue growth acceleration, potentially improving Bookings growth in H2 FY'27 and revenue growth acceleration in FY'28

    60% confidence
  • Margin targets may be lowered as company focuses on accelerating top-line growth and ensuring product portfolio is relevant in upcoming Agentic AI world

    60% confidence
  • Some customers are already replacing third-party point solution application functionality by running workflows directly in Snowflake

    60% confidence
  • Flex Credit revenues expected to start ramping up in fiscal year 2027 for new agentic offerings on outcome-based pricing

    60% confidence
  • Company has not seen any mass piping of data out of Salesforce to date

    60% confidence
  • AI native revenue is likely less than 2% but may have already helped drive Q4 beat

    60% confidence
  • Workday's integrated data model across HCM and Finance provides advantage as it increasingly sells the full suite

    60% confidence
  • Companies are coming back to Salesforce after testing solutions from AI startups like Sierra AI and Decagon AI, and after trying DIY AI using OpenAI and Anthropic LLMs

    60% confidence
  • Workday used to generate 60% of growth through existing customer base and 40% through new customers, but new customer growth is now slower

    60% confidence
  • Salesforce is doing all of the right things, but the share price will not likely react until Salesforce can demonstrate stability in its core business and demonstrate continued success and adoption of Agentforce along with Data Cloud

    60% confidence
  • Workday prices initial contracts based on customer employee base size with three-year minimum commitment, with renewals reflecting business growth, CPI inflation, and new functionality

    60% confidence
  • Snowflake is committed to maintaining product gross margins at 75% this year despite AI products creating some gross margin headwind

    60% confidence
  • Salesforce believes it is well-positioned to be a winner in the new agentic layer due to having customer context, systems of work, Atlas Reasoning Engine for agency, and engagement layer with Slack

    60% confidence

Data points we hold from this source

Snowflake Inc. · gross margin target75 percent
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com